Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rendong Yang

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Nature|April 25, 2014
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancerIrfan A Asangani, Vijaya L Dommeti, Xiaoju Wang, et al.
Science Advances|November 27, 2024
EZH2 directly methylates PARP1 and regulates its activity in cancerQingshu Meng, Jiangchuan Shen, Yanan Ren, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Diverse <i>AR</i> Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate CancerYingming Li, Rendong Yang, Christine M Henzler, et al.
Nature Immunology|April 4, 2017
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survivalCasey D S Katerndahl, Lynn M Heltemes-Harris, Mark J L Willette, et al.
The Journal of Clinical Investigation|November 18, 2025
EZH2 crosstalk with RNA methylation promotes prostate cancer progression through modulation of m6A autoregulation pathwayYang Yi, Joshua Fry, Chaehyun Yum, et al.
Molecular Cancer Research : MCR|May 29, 2020
Targeting RET Kinase in Neuroendocrine Prostate CancerHalena R VanDeusen, Johnny R Ramroop, Katherine L Morel, et al.
Nature Communications|March 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signalingYongyong Yang, Ting-You Wang, Joshua Fry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Molecular Oncology|February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Nature|April 25, 2014
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancerIrfan A Asangani, Vijaya L Dommeti, Xiaoju Wang, et al.
Science Advances|November 27, 2024
EZH2 directly methylates PARP1 and regulates its activity in cancerQingshu Meng, Jiangchuan Shen, Yanan Ren, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Diverse <i>AR</i> Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate CancerYingming Li, Rendong Yang, Christine M Henzler, et al.
Nature Immunology|April 4, 2017
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survivalCasey D S Katerndahl, Lynn M Heltemes-Harris, Mark J L Willette, et al.
The Journal of Clinical Investigation|November 18, 2025
EZH2 crosstalk with RNA methylation promotes prostate cancer progression through modulation of m6A autoregulation pathwayYang Yi, Joshua Fry, Chaehyun Yum, et al.
Molecular Cancer Research : MCR|May 29, 2020
Targeting RET Kinase in Neuroendocrine Prostate CancerHalena R VanDeusen, Johnny R Ramroop, Katherine L Morel, et al.
Nature Communications|March 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signalingYongyong Yang, Ting-You Wang, Joshua Fry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Molecular Oncology|February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Pageof 7